Carl Icahn No Longer Holds Stake in Genzyme (GENZ)
More News related to GENZ
- Baird Reiterates a 'Neutral' Rating on Genzyme (GENZ); Long-Term Implications Still Evolving
- Genzyme (GENZ) Begins Shipments of Cerezyme and Fabrazyme from Allston Plant
- Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
- Citigroup Upgrades Genzyme (GENZ) to Buy
- Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake
Carl Icahn no longer holds a stake in Genzyme (Nasdaq: GENZ), according to his fund's 13F for quarter ended 12/31/07. Icahn held 1,518,463 shares at the quarter ended 9/30/07.
Related Categories
Insider TradesStocks Mentioned
+0.41Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
